They have also shown that CRC cells, which express high levels of ANGPTL2, may develop resistance to chemotherapy; therefore, attenuating ANGPTL2 signaling in tumor cells during treatment should be considered [38]. This evidence concerns the gene ANGPTL2 and neoplasm.